NEWS | February 23, 2022
Adrenal Insufficiency and Covid 19 - how can we best help our patients with Adrenal Insufficiency during the ongoing Covid-19 pandemic?
Patients with Adrenal Insufficiency (both Primary Adrenal Insufficiency [PAI] and Secondary Adrenal Insufficiency [SAI]) have a higher morbidity and mortality rate than healthy controls primarily due to infection. Learn how to best help patients with Adrenal Insufficiency during the ongoing Covid-19 pandemic.
NEWS | January 2022
María Del Mar Morales Hernández, MD, received the Dr. Lewis E Braverman Endocrine Fellow in Training Educational Grant in 2020. Read about her memorable experience and how to apply for this one-of-a-kind grant program.
NEWS | December 9, 2021
Patients with DM who are referred to endocrine specialists for insulin pump and sensor therapy require special attention to mental health well-being and readiness. Learn strategies for how to facilitate greater patient engagement and self-empowerment when starting insulin pump and sensor therapy.
NEWS | December 7, 2021
Diabetes Mellitus is a worldwide growing problem with significant associated morbidity and mortality, as well as financial burden. One major contributor is a delay in treatment due to clinical inertia. Learn how to combat clinical inertia in diabetes patients.
NEWS | November 9, 2021
Diabetes mellitus is a globally prevalent chronic disease that directly caused 1.5 million deaths worldwide in 2019. Hypertriglyceridemia is exceedingly common in diabetes mellitus, and there is growing evidence that it contributes to residual cardiovascular risk. Learn how hypertriglyceridemia in patients with diabetes mellitus can be managed.
The statements and opinions expressed in the articles are solely those of the authors and not of AACE. The information, opinions, and recommendations presented in the articles are for general information only and any reliance on or use of the information provided is done at your own risk.